On Wednesday, Rovi Corporation (NASDAQ:ROVI)’s shares inclined 3.45% to $10.49.
Rovi Corporation (ROVI) and Panasonic Avionics Corporation declared a planned partnershipin which Panasonic will use Rovi’s metadata to manage the programming guide for its global inflight television service, eXTV.
Panasonic, the leading provider of inflight entertainment and communications (IFEC) solutions, selected Rovi because of the company’s extensive experience working with service providers and consumer electronics manufacturers in creating personalized entertainment discovery experiences. As entertainment catalogs continue to grow, Rovi metadata is the foundation that enables consumers to easily find and watch their favorite content. In the first phase of this planned relationship Panasonic will use Rovi metadata to manage its entertainment inventory and provide programming information for internationally recognized live television channels.
Rovi Corporation provides integrated solutions for the discovery and personalization of digital entertainment to service providers and consumer electronics (CE) industry worldwide.
ResMed Inc. (NYSE:RMD)’s shares gained 0.67% to $50.96.
ResMed Inc. (RMD) declared it will report its first quarter of fiscal year 2016 results on Thursday, October 22, 2015, after the New York Stock Exchange market close. A press release with ResMed’s results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to talk about operating results and future outlook.
ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and administration of respiratory disorders with a focus on sleep-disordered breathing (SDB). Its products comprise airflow generators, such as CPAP, VPAP and AutoSet systems for the titration and treatment of SBD; and masks, motors, and diagnostic products.
At the end of Wednesday’s trade, Albemarle Corporation (NYSE:ALB)‘s shares surged 3.69% to $44.10.
Albemarle Corporation (ALB), a leader in the global specialty chemicals industry, declared recently that it will release its third quarter 2015 earnings after the NYSE closes on Wednesday, November 4, 2015.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company’s Performance Chemicals segment offers brominated flame retardants under the Saytex brand; mineral-based flame retardants under the Martinal and Magnifin brands; and elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and bromine fine chemicals that are used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing, and various other industrial applications.
Xylem Inc (NYSE:XYL), ended its Wednesday’s trading session with 2.69% gain, and closed at $32.85.
At its Analyst & Investor Day in New York City, Xylem Inc. (XYL), a leading global water technology company, will outline its five-year strategy to drive profitable growth. Xylem President and CEO Patrick Decker will provide an overview of the Company’s plans to drive above-market organic growth and its balanced capital deployment strategy, which comprises accelerated acquisition activity. Other members of Xylem’s senior leadership will also present at the event.
Xylem also reaffirmed its full-year outlook, counting full-year 2015 revenue of about $3.7 billion, a decrease of six to seven percent from the full-year 2014 results. On an organic basis, Xylem anticipates to generate revenue growth of about one to two percent.
Full-year 2015 adjusted operating income is predictable to be in the range of $470 million to $483 million, resulting in adjusted earnings per share of $1.82 to $1.87. Not Taking Into Account the projected unfavorable impact of foreign exchange translation, Xylem’s adjusted earnings per share growth expectations are in the range of four to seven percent over the comparable full-year 2014 results. The Company’s outlook for projected restructuring and realignment costs of $20 million for the year is unchanged.
Xylem Inc. engages in the design, manufacture, and application of engineered technologies for the water and wastewater applications. The company operates in two segments, Water Infrastructure and Applied Water.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
